Pharmaceuticals News and Research

RSS

Regeneron Pharmaceuticals expands ophthalmology portfolio

Regeneron Pharmaceuticals, Inc. today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previously included in Regeneron's antibody collaboration with Sanofi.

3 May 2013

Cambrex sales increase by 5.7% in first quarter 2013

Cambrex Corporation reports results for the first quarter ended March 31, 2013.

3 May 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance of a U.S. patent covering methods of treatment and formulations for its clinical-stage compound, 2-methoxyestradiol.

3 May 2013

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals, is pleased to announce the UK launch of Prenoxad Injection, the world's first licensed emergency treatment for acute opioid related overdose for use at home or other non-medical settings.

3 May 2013

Viewpoints: S.C. House race spotlights Dems' discomfort with health law; Cannon, Cohn offer contrasting views of Medicaid study

The media tittering over Mrs. Colbert Busch's decision to publicly slap the former Republican governor over his extramarital affair obscured the more notable political comment of the night.

3 May 2013

Boehringer Ingelheim Pharmaceuticals, Eli Lilly launch SGLT disease education initiative

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the launch of an educational campaign designed to provide healthcare professionals with a greater understanding of the role sodium glucose co-transporters play in maintaining blood sugar balance, or glucose homeostasis.

3 May 2013

Hospitals warn of lost jobs, patient services after proposed payment changes

Changes in how hospitals are paid make news in Minnesota -- where the state's largest health plan will delay a new payment system -- and Maryland -- where hospitals say a cut in pay to them will mean fewer jobs and patient services.

3 May 2013

Tosoh Bioscience announces GPC glossary and column selection mobile app

Tosoh Bioscience LLC has announced the availability of the GPC Glossary and Column Selection Guide app, which offers easy access to 200 Gel Permeation Chromatography (GPC) terms and a GPC column selection wizard for precise directions to the ideal GPC columns for polymer molar mass distribution characterization.

2 May 2013

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from AUGMENT/COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) for the treatment of Chronic Obstructive Pulmonary Disease (COPD), delivered in the Pressair™ inhaler (Genuair® outside the USA).

2 May 2013

AcelRx Pharmaceuticals reports clinical results of Sufentanil NanoTab PCA System for acute pain treatment

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.

2 May 2013

New online resource provides practical guidance on caring for patients with dysphagia

Healthcare professionals caring for patients with dysphagia (swallowing difficulties) now have access to a new and comprehensive online resource called 'Medicines Optimisation in Patients with Dysphagia'.

2 May 2013

New hope for patients with myotonic dystrophy

There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living human cells, an important first step toward developing a pharmaceutical treatment for the as-yet untreatable disease.

2 May 2013

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.

30 Apr 2013

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.

30 Apr 2013

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.

29 Apr 2013

Averica Discovery Services establishes research collaboration with Worcester Polytechnic Institute

Averica Discovery Services, a contract research organization with specialized expertise in small molecule analysis and purification, today announced that it has established a research collaboration with the Department of Chemistry and Biochemistry at Worcester Polytechnic Institute.

29 Apr 2013

Absorption Pharmaceuticals to obtain patent for Promescent medication

Absorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation.

29 Apr 2013

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ILUVIEN®, the first sustained release pharmaceutical product for the treatment of chronic diabetic macular edema, is now available in the United Kingdom.

29 Apr 2013

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus.

29 Apr 2013

Oramed to report results of T1DM oral insulin formulation at Diabetes Summit 2013

Oramed Pharmaceuticals Inc., a developer of oral delivery systems of drugs currently administered by injection, announced today that its abstract, entitled "Oral insulin capsules toward management of Type 1 diabetes mellitus," will be presented at the Global Technology Community Diabetes Summit 2013.

29 Apr 2013

Pharmaceuticals News and Research

Regeneron Pharmaceuticals expands ophthalmology portfolio

Cambrex sales increase by 5.7% in first quarter 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Viewpoints: S.C. House race spotlights Dems' discomfort with health law; Cannon, Cohn offer contrasting views of Medicaid study

Boehringer Ingelheim Pharmaceuticals, Eli Lilly launch SGLT disease education initiative

Hospitals warn of lost jobs, patient services after proposed payment changes

Tosoh Bioscience announces GPC glossary and column selection mobile app

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

AcelRx Pharmaceuticals reports clinical results of Sufentanil NanoTab PCA System for acute pain treatment

New online resource provides practical guidance on caring for patients with dysphagia

New hope for patients with myotonic dystrophy

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Averica Discovery Services establishes research collaboration with Worcester Polytechnic Institute

Absorption Pharmaceuticals to obtain patent for Promescent medication

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

Oramed to report results of T1DM oral insulin formulation at Diabetes Summit 2013

Event guide: World ADC San Diego eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence